Results 151 to 160 of about 10,075 (184)

Prevalence and determinants of adverse events following ChAdOx1 nCoV-19 vaccination (COVISHIELD) - A retrospective cohort study among healthcare workers in central Karnataka, India. [PDF]

J Family Med Prim Care, 2023
Davalagi SB, Nayak VP, Ghose A, Marakatti SS, Kasturi ES, Maganahalli AS.   +5 more
europepmc   +1 more source

Kaposi Sarcoma as a Possible Cutaneous Adverse Effect of ChAdOx1 nCov-19 Vaccine: A Case Report. [PDF]

Vaccines (Basel)
Li YH, Lin YT, Chuang SH, Yang HJ.
europepmc   +1 more source

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine. [PDF]

NPJ Vaccines, 2023
Benkeser D, Fong Y, Janes HE, Kelly EJ, Hirsch I, Sproule S, Stanley AM, Maaske J, Villafana T, Houchens CR, Martins K, Jayashankar L, Castellino F, Ayala V, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Carpp LN, Randhawa AK, Andrasik MP, Kublin JG, Isaacs MB, Makhene M, Tong T, Robb ML, Corey L, Neuzil KM, Follmann D, Hoffman C, Falsey AR, Sobieszczyk M, Koup RA, Donis RO, Gilbert PB, AstraZeneca AZD1222 Clinical Study Group, Immune Assays Team, United States Government (USG)/CoVPN Biostatistics Team.   +42 more
europepmc   +1 more source

Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine

European Heart Journal - Case Reports, 2021
openaire   +2 more sources

Examining the inconclusive link: Minimal change disease and ChAdOx1 nCoV-19 vaccination. [PDF]

J Family Med Prim Care
Mannava AS.
europepmc   +1 more source

The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population. [PDF]

Vaccines (Basel)
Damour A, Faure M, Landrein N, Ragues J, Ardah N, Dhaidel H, Lafon ME, Wodrich H, Basha W.   +8 more
europepmc   +1 more source

Neutralizing Anti-SARS-CoV-2 Antibody Response to COVID-19 Vaccines-ChAdOx1-nCoV-19 and BBV152 Among Hemodialysis Patients. [PDF]

Indian J Nephrol
Selvanathan DK, Parthasarathy R, Rohit A, Venkataramanan S, Dsouza C.   +4 more
europepmc   +1 more source

Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses. [PDF]

Hum Vaccin Immunother
Padilla-Bórquez DL, Matuz-Flores MG, Hernández-Bello J, Rosas-Rodríguez JA, Turrubiates-Hernández FJ, García-Arellano S, González-Estevez G, Ceja-Galvez HR, Oregon-Romero E, López-Reyes A, Muñoz-Valle JF.   +10 more
europepmc   +1 more source

ChAdOx1 nCoV-19 vaccination generates spike-specific CD8⁺ T cells in aged mice. [PDF]

Immunol Cell Biol, 2023
Foster WS, Newman J, Thakur N, Spencer AJ, Davies S, Woods D, Godfrey L, Ross SH, Sharpe HJ, Richard AC, Bailey D, Lambe T, Linterman MA.   +12 more
europepmc   +1 more source